Anti cancer drugs

Classes 

Anti cancer drugs 

Angiogenesis inhibitors 

• Bevacizumab

• Sunitinib

• Sarafenib

BCR-ABL tyrosine kinase inhibitors 

1st Generation-

• Imatinib 


2nd Generation (for imatinib resistant CML pt)-

• Dasatinib

• Nilotinib


3rd Generation (for T315I mutated CML pt)-

• Ponatinib

CD20 inhibitor

• Rituximab 

EGF receptor inhibitor 

HER-1 inhibitor:

• Gefitinib 

• Erlotinib

• Cetuximab


HER-2 inhibitor:

• Transtizumab 

• Lapatinib 

EGF receptor (HER-1) inhibitor 

• Transtizumab

• Lapatinib

Proteasome inhibitor 

• Bortezomib 

mTOR inhibitors 

• Everolimus (oral)

• Temsirolimus (iv)



Imatinib use- 


BCR-ABL mutation:

1. Acute lymphoblastic leukemia (ALL)

2. Chronic myelogenous leukemia (CML) 


c-kit mutation:

1. GIST 


Platelet derived growth factor receptor (PDGFR) mutation:

1. Dermatofibrosarcoma protuberans 




Reference: 

1. Essentials of Medical Pharmacology, KD Tripathi, 8th edition, P. No. 928-32 


View in web app Open in TCML App